logo BDSP

Base documentaire


  1. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey.

    Article - En anglais

    An estimate of the antibiotic cost of nosocomial infections (NI) was made in a university hospital group based on data collected in adult inpatients enrolled in the French national prevalence survey in 1996.

    Among the 6839 study patients, 636 (9.3%) presented with at least one NI, of these, data on antimicrobial treatment were available for 480.

    The overall daily antibiotic cost was estimated between FF 49439 and 103 526, resulting in FF 103 to 216 per infected patient.

    The most expensive antibiotic treatment was prescribed in intensive care patients, for pneumonia for device-related NI, or for multi-resistant bacterial infections.

    Non-documented NI represented about 20% of the overall antibiotic cost.

    Betalactam antibiotics, especially third generation cephalosporins, and parenteral fluoroquinolones were the most expensive antimicrobial drugs.

    The cost of antibiotic treatment for NI represents a significant part of hospital expenditure that should be reduced by better control of highly expensive prescriptions.

    Mots-clés Pascal : Chimiothérapie, Antibactérien, Coût, France, Europe, Epidémiologie, Service hospitalier, Traitement, Infection nosocomiale, Prévalence, Localisation, Homme, Economie santé

    Mots-clés Pascal anglais : Chemotherapy, Antibacterial agent, Costs, France, Europe, Epidemiology, Hospital ward, Treatment, Nosocomial infection, Prevalence, Localization, Human, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0411749

    Code Inist : 002B02S02. Création : 22/03/2000.